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Abstract
Background: RFI-641, a small dendrimer-like compound, is a
potent and selective inhibitor of respiratory syncytial virus (RSV),
which is currently a clinical candidate for the treatment of upper
and lower respiratory tract infections caused by RSV. RFI-641
inhibits RSV growth with an IC50 value of 50 nM and prevents
syncytia formation in tissue culture. RSV contains of three surface
glycoproteins, a small hydrophobic (SH) protein of unknown
function, and attachment (G) and fusion (F) proteins that enable
binding and fusion of virus, respectively, with target cells. Because
of their role in attachment and fusion, the G and F surface
proteins are prominent targets for therapeutic intervention. RFI-
641 was previously shown to bind purified preparations of RSV
fusion protein. Based on this observation, in conjunction with the
biological results, it was speculated that the fusion event might be
the target of these inhibitors.
Results : A fusion assay based upon the relief of self-quenching
of octadecyl rhodamine R18 was used to determine effects of the
inhibitors on binding and fusion of RSV. The results show that
RFI-641 inhibits both RSV^cell binding and fusion events. The
inhibition of RSV is mediated via binding to the fusion protein on
the viral surface. A closely related analog, WAY-158830, which is
much less active in the virus-infectivity assay does not inhibit
binding and fusion of RSV with Vero cells.
Conclusions: RFI-641, an in vivo active RSV inhibitor, is shown
to inhibit both binding and fusion of RSV with cells, events that
are early committed steps in RSV entry and pathogenicity. The
results described here demonstrate that a non-peptidic, small
molecule can inhibit binding and fusion of enveloped virus
specifically via interaction with the viral fusion protein. ß 2001
Elsevier Science Ltd. All rights reserved.
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1. Introduction
Respiratory syncytial virus (RSV) is a member of the
family Paramyxoviridae and the genus Pneumovirus. Hu-
man RSV is a major cause of respiratory tract infection in
young children and infants and is an important cause of
community acquired respiratory infection among hospital-
ized adults [1]. RSV is reported to cause an estimated
91 000 hospitalizations and 4500 deaths annually in the
USA [2,3]. Recent clinical studies have probed the role
of RSV infections as the cause of a variety of pathological
conditions. It is clear that the current understanding of the
RSV interaction with target cells is considerably less than
that of in£uenza, for which RSV infection is frequently
confused.
Entry of enveloped viruses into cells occurs via two
general routes, both of which are dependent on recogni-
tion of speci¢c cell surface receptors and membrane fu-
sion. In certain viruses, such as orthomyxovirus, cell entry
is via adsorptive endocytosis, a process in which the virus
particle is delivered to the intracellular endosomal com-
partment [4^7]. Viral membrane fusion is then mediated
at slightly acidic pH by the surface glycoproteins [8]. In
paramyxoviruses such as RSV and Sendai virus, adsorp-
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tion and membrane fusion occur at the cell surface at
neutral pH thereby allowing direct entry of the viral capsid
into the cytoplasm [9,10]. RSV contains three surface gly-
coproteins as spike-like projections, namely, G (attach-
ment), F (fusion) and SH (small hydrophobic) proteins
[11]. The fusion protein in RSV, similar to other para-
myxoviruses, is synthesized as a precursor, Fo, which is
subsequently activated by cleavage to two fragments F1
and F2 that are linked by a disul¢de bond. F2 is highly
glycosylated and, similar to other enveloped viruses, ap-
pears to be involved in target cell recognition and attach-
ment providing a backup to the G attachment protein.
Several years ago a screening program at Wyeth-Ayerst
Research identi¢ed a potent and speci¢c inhibitor for
RSV, the disulfonated stilbene CL-309623, from a diverse
20 000 compound library. After the preparation of some
150 analogs, the biphenyl analog RFI-641 (IC50 50 nM)
was chosen for evaluation in the clinic (see structures in
Scheme 1 below). The analogs, CL-309623, RFI-641 and
WAY-158830, were synthesized as outlined in Scheme 1
[12].
3-Nitrobenzenesulfonyl chlorides 3, 4 were converted to
the corresponding amides 5, 6 by reaction with glycyl-
amide under Shotten^Baumann conditions. The second
glycylamido chain was added by reaction with sodium
hydride and bromoacetamide in DMF. The nitro group
in the compounds 7, 8 was reduced to the amino group by
treatment with iron powder in water/acetic acid to give the
amino compounds 9, 10. Next, nucleophilic addition of 9,
10 to cyanuric chloride under controlled conditions led to
the disubstituted monochlorotriazines 11, 12 in good yield.
Condensation of the substituted triazines 11, 12 with the
core part, 1,1P-diaminobiphenyl-3,3P-disulfonic acid, led to
RFI-641 and WAY-158830. The individual compounds
were isolated by preparative high performance liquid chro-
matography. The IC50 values of RFI-641, WAY-158830
and CL-309623 in the viral growth assay are 50 nM, 25
WM and 150 nM respectively.
The biphenyl analogs and other small dendrimer-like
analogs based on stilbene and biphenyl cores were shown
to prevent syncytia formation in cell cultures. Evidence for
direct binding [12] of the stilbene inhibitor, CL-309623,
and the more potent biphenyl analog RFI-641 with a pu-
ri¢ed preparation of F protein was obtained using a £uo-
rescence binding assay. The goal of the present studies has
been to determine if the compounds speci¢cally inhibit
attachment of virus to target cells as well as the virus^
cell fusion event. Towards this goal we have implemented
a £uorescence-dequenching assay [13] to determine the ef-
fect of RFI-641 on attachment and fusion against a wild
type (A2 strain) and a mutant (cp-52) virus which contains
only the fusion protein on its surface. The mutant virus is
a cold-passaged strain that e¡ectively infects mammalian
cells in tissue culture even though it lacks the small hydro-
phobic (SH) and attachment (G) protein [14]. The fusion
protein in the mutant cp-52 strain has one amino acid
substitution at position 218 (Glu to Gly) in the F2 domain
[14]. Since the mutant virus has only one surface glyco-
protein, the virus is a good model to study the e¡ect of
inhibitors on attachment and fusion. The results of the
£uorescence-dequenching assay show that RFI-641 inhib-
its both virus^cell attachment and fusion events.
Scheme 1.
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2. Results and discussion
2.1. Inhibition of attachment and fusion of RSV with Vero
cells using the £uorescence microscopy method
RSV can infect a wide variety of human and animal
cells. The virus can be cultured in Vero cells, HEp-2,
HeLa, and CV-1. In this work we chose green monkey
epithelial cells (Vero) to study RSV fusion because the
virus primarily infects the epithelial cell lining the respira-
tory tract. Fusion of octadecyl rhodamine R18-labeled
RSV with unlabeled Vero cells can be directly observed
in a £uorescence microscope as an increase in quantum
yield of R18 due to membrane fusion events and the re-
sulting dilution of dye in the merged membrane. The £uo-
rescence microscopy assay is based on a £uorescence-de-
quenching method previously described [13]. Brie£y the
assay involves labeling the virus with the rhodamine dye
at self-quenching concentrations and then fusing with
Vero cells. Upon membrane merger, during viral fusion,
the self-quenching is relieved due to dye spread.
RSV binds cells both at 4‡C and 37‡C but fusion occurs
only when the temperature is raised above 18‡C. The ex-
perimental strategies that were used to determine the ef-
fects of RFI-641 on cell entry, namely, the combined
events of virus^cell attachment and fusion, virus^cell at-
tachment and virus^cell fusion events alone, are shown in
Scheme 2.
To determine qualitatively the e¡ect of inhibitor on
combined RSV attachment and fusion events according
to Scheme 2, left, above, R18-labeled RSV was added to
Vero cells in a 12-well microtiter plate. Vero cells and
virus were incubated either in the absence or presence of
2 WM of the inhibitor for 30 min at 37‡C. The plate was
imaged using a £uorescence microscope after washing out
the unattached virus. In this experiment, only those virions
that are attached speci¢cally to Vero cells can undergo
fusion and any inhibition of attachment by the inhibitor
will result in a lesser amount of fusion. On the other hand,
any inhibition of fusion alone will also result in diminished
dye spread. The inhibitory e¡ects of RFI-641 on fusion
and the lack of it in the case of WAY-158830 are shown in
the £uorescence images in Fig. 1. Fig. 1A,B correspond to
fusion events of wild type and mutant strains of RSV (A2
and cp-52) respectively, in the absence of inhibitor. In Fig.
1B, the increase in £uorescence of R18 due to fusion of
cp-52 with cells is signi¢cantly less than the fusion of
A2 strain shown in Fig. 1A. Since cp-52 virus lacks the
G protein, which directs speci¢c attachment of RSV with
cells, the lower extent of R18 £uorescence would be indi-
cative of lower e⁄ciency of fusion in the mutant strain
resulting from a fewer number of attached viruses and
Scheme 2.
CHBIOL 107 5-7-01 Cyaan Magenta Geel Zwart
Research Paper RFI-641 inhibits RSV entry into cells V. Razinkov et al. 647
direct inhibition of fusion. The £uorescence images shown
in Fig. 1C,D correspond to attachment and fusion of the
viruses in the presence of 2 WM of RFI-641. The £uores-
cence of R18 due to fusion, shown in Fig. 1C,D, is sig-
ni¢cantly quenched compared to those in Fig. 1A,B; thus
the lack of increase in R18 £uorescence could be due to
inhibition of virus^cell attachment and/or fusion. The in-
hibitor alone does not interact with the R18 dye and there-
Fig. 1. E¡ect of RFI-641 and WAY-158830 on RSV attachment and fusion events at 37‡C using the £uorescence microscopy method. Virus and inhibi-
tor were added to a 12-well Corning1 plate containing adherent Vero cells in MEM at 37‡C. The inhibitor, cell and virus mixture was incubated for
30 min at 37‡C. After removal of the unattached virus, cells were imaged using a £uorescence microscope. A and B correspond to fusion of A2 and
cp-52 strains with Vero cells in the absence of inhibitor respectively. C and D correspond to A2 and cp-52 strains in the presence of 2 WM of RFI-641
respectively. E and F are due to fusion of A2 and cp-52 strains in the presence of 2 WM WAY-158830 respectively.
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fore has no direct e¡ect on the quantum yield of the £uo-
rescence of the dye.
The structurally related analog WAY-158830 consisting
of a methyl group in the peripheral benzenesulfonamides
(see Scheme 1 for structures) was also tested in the fusion
assay as a negative control. WAY-158830, which has weak
inhibitory activity in the virus growth assay (IC50 values of
WAY-158830 and RFI-641 are 25 WM and 50 nM respec-
Fig. 2. E¡ect of RFI-641 and WAY-158830 on RSV^cell attachment at 4‡C using the £uorescence microscopy method. Labeled virus was allowed to
bind to Vero cells grown on a 12-well Corning1 plate at 4‡C. Inhibitor was added to cells immediately before the addition of virus. After incubation
at 4‡C for 30 min, unattached virus particles were removed and cells were incubated at 37‡C for 30 min. Cells were imaged using a £uorescence micro-
scope at ambient temperature. A ^ A2 strain in the absence of inhibitor; B ^ cp-52 strain in the absence of inhibitor; C ^ A2 strain with 2 WM RFI-
641; D ^ cp-52 strain with 2 WM RFI-641; E ^ A2 virus with 2 WM WAY-158830; F ^ cp-52 virus with 2 WM WAY-158830.
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tively [12]), is also less selective against a panel of viruses.
Fig. 2E,F are due to fusion of labeled virus with cells in
the presence of the inactive analog, WAY-158830. WAY-
158830 inhibits virus fusion weakly as evidenced by relief
of R18 self-quenching. In this instance, the extent of self-
quenching is comparable to the control and therefore the
£uorescence is signi¢cantly higher than those observed in
the presence of RFI-641.
As mentioned above, it has recently been shown that the
cold-passaged mutant virus cp-52 infects mammalian cells
in tissue cultures [14] even though it lacks the attachment
protein. This observation suggests that the fusion protein
is capable of mediating attachment on its own. Since the
£uorescence microscopy results of viral fusion described
above have shown that RFI-641 blocks the interaction
(binding and/or fusion) of RSV with Vero cells, the next
step was to quantify the inhibition of attachment and fu-
sion. However, the molecular recognition aspects of RSV^
cell interactions and fusion are uncertain, unlike the case
of retroviruses such as HIV and also for in£uenza where
cell surface receptors and fusion mechanisms are fairly
well understood. Therefore, a ‘temperature-shift’ experi-
ment was set up in an attempt to separate virus^cell at-
tachment from fusion events [15,16]. This experiment is
based on our previous observations that have shown
that RSV can be co-incubated with target cells at low
temperatures, namely 4‡C, without fusion, and when the
temperature is raised to 37‡C the virus becomes fusion
competent and viable in a tissue culture assay [17].
To determine the e¡ect of inhibitor on fusion alone
(Fig. 2) according to Scheme 2, right, above, the virus
was pre-incubated with Vero cells at 4‡C to enable attach-
ment without triggering fusion. After this attachment step,
the unattached virus was removed and inhibitor added to
the virus^cell complex prior to triggering fusion at 37‡C.
The inhibitory e¡ects of RFI-641 on fusion and the lack of
it in the presence of WAY-158830 are qualitatively similar
to the results described in Fig. 1.
Fig. 3 shows the e¡ect of inhibitors on virus^cell attach-
ment at 4‡C, again using the £uorescence microscopy
method, and the strategy shown in Scheme 2, middle,
above. In this experiment, labeled virus was added to
Vero cells at 4‡C and the inhibitor was added immediately
before addition of virus. To enable attachment, the virus,
cells and inhibitor mixture was incubated at 4‡C for 30
min. At the end of the binding step, the medium contain-
ing unattached virus and compound was removed and the
temperature increased to 37‡C to induce fusion. Based on
this assay, RFI-641 inhibits virus^cell attachment (Fig.
3C,D) whereas WAY-158830 does not signi¢cantly inhibit
attachment at 2 WM (Fig. 3E,F).
RSV attachment is reported to be mediated through the
SH and G glycoproteins via heparin moieties on the target
cell surface [18,19]. The fact that the cp-52 mutant lacking
the SH and G proteins is infectious and is capable of
attachment and fusion (results of fusion assays shown
here) indicates the existence of an alternative F-mediated
pathway for RSV attachment. Hypothetically, within a
wild type population some viruses may use this F-medi-
ated pathway for virus entry. We propose that RFI-641
inhibits these attachment and fusion events by interaction
with fusion protein in the wild type and mutant virus
strains.
2.2. R18 fusion assay using Vero cells in suspension
2.2.1. RSV binding to cells in the absence of inhibitor
To di¡erentiate the early events of virus binding and
fusion that are speci¢cally blocked by inhibitor and to
quantify such e¡ects, the fusion assay was implemented
using cells in suspension. The R18 dye spread assay has
been used with cells in suspension by many other investi-
gators and is a commonly used fusion assay for the in£u-
enza and Sendai viruses and RSV [15,16] as well. In the
attachment experiment, virus was incubated with cells ei-
ther at 37‡C (Fig. 4aA) or at 4‡C (Fig. 4aB). The attached
virus was sedimented by centrifugation and SDS detergent
added to the pellet to relieve self-quenching by complete
randomization of the dye. The extent of attached virus
was estimated as a ratio of the labeled virus in the pellet
relative to the total amount of virus added prior to cen-
trifugation. The estimate of viral particles is based upon
randomization of the R18 dye in the presence of detergent.
At 37‡C (Fig. 4aA) the increase in £uorescence scores as
fusion but it does not account for the total number of
virus particles attached to cells. The total virus particles
will be proportional to the £uorescence intensity only
when the R18 dye is completely randomized and de-
quenched in solution.
To determine if aggregated virus would co-sediment
with bound virus in experiments such as the ones shown
in Fig. 4a, the following control experiment was per-
formed. Labeled virus was centrifuged at 4‡C in the ab-
sence of cells, and SDS was added to the supernatant to
estimate the virus in this fraction after randomization of
dye. The amount of virus in the supernatant was estimated
to be within 2% of the total because the standard centri-
fugation conditions did not pellet free or aggregated virus.
The result of this control experiment enabled the quanti-
¢cation of the bound virus without interference from free
virus particles.
In a typical attachment experiment, less than 10% of the
total number of the A2 virus and about half as much of
the cp-52 virus are bound to Vero cells at 37‡C (Fig. 4aA).
The same experiment at 4‡C showed that about 20% of the
wild type strain and the same amount of the mutant strain
are attached to cells as shown in Fig. 4aB. Thus it is
evident that nearly twice as much virus is bound at 4‡C
than at 37‡C. Nevertheless, the results show that the cp-52
mutant virus binds cells albeit weakly at 37‡C, via the
fusion protein, despite the lack of G protein. The extent
of binding of 20% at the lower temperature is comparable
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to a reported 30% binding observed for Sendai virus [20^
22].
To determine the stability of the virus^cell complex and
the percentage of virus that would spontaneously dissoci-
ate from cells (in the absence of inhibitor) in a fusion
experiment (Scheme 2, right), the virus was pre-bound to
cells at 4‡C and then transferred to 37‡C after removing
the unattached or free virus. The results shown in Fig. 4aC
Fig. 3. E¡ect of RFI-641 and WAY-158830 on RSV^cell fusion at 37‡C using the £uorescence microscopy method. Labeled virus was allowed to bind
to Vero cells on a 12-well Corning1 plate at 4‡C. After incubation at 4‡C for 30 min, unattached virus particles were removed. The plate was incu-
bated at 37‡C for 30 min to induce fusion. The cells were imaged in the £uorescent microscope at ambient temperature following fusion. A and B ^ fu-
sion of A2 and cp-52 strains respectively in the absence of inhibitor; C and D ^ fusion of A2 virus and cp-52 strains in the presence of 2 WM RFI-641;
E and F ^ A2 and cp-52 strains respectively in the presence of 2 WM WAY-158830.
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would suggest that approximately 40% of the bound virus
dissociated from the cells, under these experimental con-
ditions. The decrease in virus binding shown in Fig. 4aC
corresponds approximately to the di¡erence in binding
observed at 37‡C and 4‡C in Fig. 4aA,B respectively.
The reversibility of binding in the temperature-shift experi-
ment in Fig. 4aC is due to the establishment of a new
equilibrium of the bound virus with unattached virus
and cells. The new equilibrium at 37‡C represents a fewer
number of binding sites for RSV on Vero cells. The experi-
ment that measures fusion event alone (as in Scheme 2,
right) would, therefore, underestimate the amount of at-
tached virus. In the case of in£uenza virus, a similar result
was observed where it was shown that an increase in tem-
perature decreases the number of binding sites [23]. Since
fusion is triggered at 37‡C in RSV, the lower binding
e⁄ciency at this temperature could result from loss of
potential binding sites due to virus^cell fusion or due to
conformational changes in the fusion protein.
2.2.2. Inhibition of RSV^cell attachment by RFI-641
The e¡ect of RFI-641 on virus binding to cells was
investigated at 37‡C according to the method described
above in the legend to Fig. 4aA. In this experiment, the
inhibitor was added to cells immediately followed by the
addition of virus. After incubating this complex for 30
min, the labeled virus in the centrifuged pellet was esti-
mated by adding detergent. Results in Fig. 4b show a dose
response of inhibition of attachment both of wild type and
mutant viruses in the presence of RFI-641. RFI-641 pro-
gressively inhibits virus^cell attachment with a maximum
value of 20% at 2 WM. Of the total virus added to Vero
cells, 20% less virus is attached in the presence of the
inhibitor than in its absence. A similar experiment at
4‡C could not be quanti¢ed due to virus aggregation issues
as evidenced by preliminary ultracentrifugation studies
(data not shown). In the attachment inhibition experi-
ments both cp-52 and wild type A2 virus strains are in-
hibited to a similar extent due to the interaction of the
inhibitor with fusion protein.
The reversible association of RFI-641 with virus was
demonstrated in the virus^cell lipid mixing assays and in
the biological plaque reduction assays as described below.
In the ¢rst assay, labeled virus was pre-incubated with
RFI-641 in phosphate-bu¡ered saline (PBS) bu¡er, at
37‡C for 5 min. The virus^inhibitor mixture was diluted
50-fold into a cuvette containing Vero cells to determine
the extent of dequenching of R18 dye. The extent of de-
quenching due to lipid mixing is identical for inhibitor-
treated virus and untreated virus particles. Alternatively,
the virus^inhibitor mixture was diluted 50-fold into media
and then added to Vero cells in a 12-well plate at 37‡C and
the resultant dye spread due to fusion was imaged using
the £uorescence microscopy method. The extent of fusion
of virus pre-mixed with inhibitor is identical to fusion of
untreated virus in both the experiments. Similarly, in the
Fig. 4. a: Estimation of attachment of RSV to Vero cells at 4‡C and
37‡C using cells in suspension. Virus was initially added to Vero cells in
suspension in the absence of inhibitor. The cells were centrifuged to sep-
arate unattached virus. The detergent was added to pellet and superna-
tant and the £uorescence of octadecyl rhodamine R18 measured at the
maximum wavelength of 560/580 nm. The percentage of attached virus
was calculated from the ratio of £uorescence of attached virus in pellet
to total £uorescence in pellet and supernatant. A ^ extent of binding of
labeled virus at 37‡C. B ^ extent of binding of labeled virus at 4‡C. C ^
extent of dissociation of labeled virus at 37‡C. b: E¡ect of RFI-641 on
attachment of A2 and cp-52 to Vero cells at 37‡C. Virus was initially
added to Vero cells in suspension at 37‡C. Inhibitor was added to cells
just before addition of virus. After 30 min incubation of mixture at
37‡C, unattached virus was separated by centrifugation. 2% sodium do-
decyl sulfate (SDS) was added to pellet consisting of cells with attached
and fused virus and to supernatant containing unattached virus. Fluo-
rescence of R18 was measured as described above. Fraction of attached
virus in the presence of 0.5, 1 or 2 WM of RFI-641 was calculated as a
ratio of £uorescence of pellet to total £uorescence of pellet and superna-
tant as described above for cp-52 (E) and A2 (a) strains.
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second assay pre-incubation of virus with inhibitor fol-
lowed by removal of inhibitor or dilution of virus did
not block infectivity in plaque assays. The results of the
experiments described here show that the biological activ-
ity and lipid mixing activity are fully resumed upon dilu-
tion of virus^inhibitor mixture or after removing inhibitor
in a washing step. These results and those shown in Fig. 4
show that RFI-641 reversibly associates with virus and
inhibits virus^cell attachment.
2.2.3. Kinetics of RSV^cell fusion
The results of the R18-dequenching assays described
above using Vero cells either in suspension or attached
to a plate provide direct evidence for inhibition of attach-
ment and fusion due to inhibitor binding to the fusion
protein. To gain further insight into the nature of the in-
hibition, namely e¡ects on the kinetics and extent of fu-
sion, dye spread due to virus^cell fusion was monitored
continuously as a function of time after pre-binding the
labeled virus to cells at 4‡C (according to Scheme 2, right).
In this experiment, inhibitor was added to the virus^cell
complex immediately before inducing fusion. After remov-
ing unattached virus particles by centrifugation, the virus^
cell complex formed at 4‡C was combined with inhibitor
in a cuvette at 37‡C. The kinetics (Fig. 5A) and extent of
fusion (Fig. 5B) were evaluated as a function of the con-
centration of the inhibitor. The rate of fusion levels o¡
and reaches steady state values after approximately 5 min
in both virus strains due to maximal increase in £uores-
cence signal after fusion of the attached virus. The fusion
rates of cp-52 and A2 virus strains are nearly identical
(Fig. 5A) because only the fusion protein is involved in
the membrane merger event. In the presence of RFI-641,
the rate of fusion as well as the normalized extent of
dequenching in R18 £uorescence are progressively inhib-
ited, until the rate reaches a value of zero (Fig. 5A). These
results suggest that RFI-641 inhibits virus^cell fusion e⁄-
ciently. The potency of fusion inhibition, 50% at approx-
imately 100 nM in the cp-52 strain and 250 nM in the wild
type strain (Fig. 5B), is in agreement with the infectivity
assays.
Since only 20% of the input virus is attached to Vero
cells under the stated conditions of the experiment, the
extent of fusion shown in Fig. 5A in the absence of inhib-
itor is equivalent to a fusion e⁄ciency of nearly 50%. In
other words, only 10% of the input virus undergoes fusion
with cells. Although this number appears small, the esti-
mated number of RSV particles fusing with cells at this
concentration is comparable to the extent of fusion of
Sendai virus [20].
In order to quantify the e¡ect of inhibitor on the com-
bined events of attachment and fusion (according to
Scheme 2, left) using the above described continuous fu-
sion assay, the inhibitor was co-incubated with virus and
Vero cells at 37‡C without removing the unattached virus
particles. In Fig. 6A, the rate of fusion of the A2 virus is
signi¢cantly slower than the corresponding fusion rates of
the attached viruses alone (see Fig. 5A). The rate of fusion
is slower because virus binding and fusion are occurring
concurrently, whereas in the fusion alone experiment (Fig.
5A) the rate is proportional to the concentration of pre-
bound virus only. Also, the fusion rates of cp-52 and A2
virus strains are nearly identical (Fig. 6A,B) because only
the fusion protein is involved in the membrane merger
event. RFI-641 inhibits attachment and fusion more e¡ec-
tively in cp-52 than in the wild type virus (Fig. 6C) due to
interaction with fusion protein only. Here again WAY-
Fig. 5. A: Kinetics of fusion of cp-52 virus after pre-attachment to cells
at 4‡C. Labeled virus was incubated with suspension of Vero cells at
4‡C for 30 min. Unattached virus was removed after centrifugation. The
pellet containing virus-bound cells was resuspended in 50 Wl of PBS and
the suspension was injected into a cuvette containing 450 Wl of PBS at
37‡C. Inhibitor was added before injection of cell/virus suspension.
Fluorescence of R18 was measured at the emission maximum in 1 min
time intervals. Dequenching (DQ) was calculated as described in Section
4. This value was normalized relative to the ¢nal DQ value at 30 min
for the respective virus in the absence of inhibitor. Kinetics of fusion of
A2 strain in the presence of 0 WM (a), 0.1 WM (E), 0.5 WM (7) and
1 WM (O) of RFI-641 respectively. Kinetic traces of fusion of cp-52
strain in the presence of 0 WM (b), 0.1 WM (F), 0.5 WM (8) and 1 WM
(R) of RFI-641 respectively. B: E¡ect of RFI-641 on extent of fusion
of A2 and cp-52 strains with Vero cells after pre-attachment of virus at
4‡C. The extent of dequenching due to fusion was estimated in the ab-
sence and presence of inhibitor and the value in the presence of inhibi-
tor was expressed as a ratio relative to the value in its absence. The
normalized values for A2 strain (a) and cp-52 virus strain (E) in the
presence of 0, 0.1 WM, 0.5 WM and 2 WM of RFI-641 are shown.
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158830 is inactive in the fusion assay apparently because it
does not inhibit attachment or fusion events (Fig. 6C). On
the basis of the fusion and attachment experiments, it
would appear that RFI-641 inhibits virus fusion more
than the attachment event. However, in the fusion experi-
ment, the ratio of inhibitor to virus is higher compared to
the attachment experiment, which would result in a greater
extent of inhibition of fusion.
Since the inhibitory e¡ects described here directly impli-
cate fusion protein as the primary target, binding experi-
ments were done with virus using a stilbene analog, CL-
309623, due to its desirable £uorescence properties,
namely, emission maximum at long wavelengths and en-
hancement in quantum yield in the presence of fusion
protein. The emission maximum of CL-309623 is centered
at 460 nm and the quantum yield increases upon interac-
tion with fusion protein [12]. In addition to these desirable
£uorescence properties, CL-309623 inhibits virus growth
with an IC50 value of 150 nM which is only three-fold
weaker than RFI-641. This analog also inhibits virus at-
tachment and fusion e⁄ciently in the R18 fusion assay as
shown in Fig. 7a. Biologically, CL-309623 and RFI-641
are identical in their mechanism of action except for the
di¡erence in potency of inhibition of RSV. CL-309623 and
RFI-641 cross-react and inhibit resistant virus strains cul-
tivated against each of these two compounds (data not
shown). Due to the equivalent response of CL-309623
and RFI-641 in the in vitro assays, CL-309623 is a good
candidate for the virus binding studies. The £uorescence
spectra of the inhibitor in the absence and presence of
mutant and wild type virus strains at 15‡C are shown in
Fig. 7b. In the presence of virus (equivalent to 5 Wg of
total protein, including envelope proteins and proteins in
the nucleocapsid), the £uorescence of CL-309623 is signi¢-
cantly enhanced. Using the molecular weight of 70 000 for
the fusion protein, the concentration of fusion protein on
the virus surface would correspond to less than 150 nM.
On the basis of the £uorescence results in Fig. 7bA, it
appears that the interaction is more pronounced with
cp-52 than with the wild type virus, possibly due to a higher
concentration of fusion protein in the mutant cp-52 virus
than in the wild type strain. Fig. 7bB shows the changes in
the £uorescence of the inhibitor in the presence of fusion
protein. It is important to note that the binding site that is
responsible for the increase in quantum yield of the CL-
309623 is present both in the cp-52 virus as well as in the
isolated fusion protein (see [12] for the isolation and pu-
ri¢cation of fusion protein). These results are consistent
with direct interaction of the inhibitor with a pre-fusogenic
conformation of the protein. The nature of the interac-
tions with a fusogenic state of the protein is not known
because such a state may only be stabilized by the target
membrane during viral fusion. For the ¢rst time it is
shown here that selective interactions of the inhibitor
with fusion protein are responsible for the observed inhi-
bition of entry of RSV into cells.
Fig. 6. A: E¡ect of RFI-641 on binding and fusion of A2 strain at
37‡C using the continuous fusion assay. Aliquots of A2 strain of virus
were injected into Vero cells in suspension. RFI-641 was added to the
cells immediately before the addition of virus. The extent of dequench-
ing was measured at 1 min time intervals as previously described. The
dequenching value in the presence of inhibitor at 0.1 WM (a), 0.2 WM
(E), 0.5 WM (7), 1 WM (O) and 2 WM (+) was expressed as a ratio rel-
ative to the dequenching value in its absence. B: E¡ect of RFI-641 on
attachment and fusion events of A2 and cp-52 strains. The extent of de-
quenching under the stated experimental conditions was estimated ac-
cording to the method described in the legend to A. The normalized
values for A2 strain (a) and cp-52 virus strain (E) in the presence of 0,
0.1 WM, 0.5 WM and 2 WM of RFI-641 are shown. C: E¡ect of WAY-
158830 on binding and fusion of A2 virus strain. The experimental con-
ditions are identical to those described for RFI-641 in A. The fusion as-
say was performed in the absence (a) and presence of 2 WM (E) or
5 WM (7) of the inhibitor.
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Fig. 7. a: E¡ect of CL-309623 on RSV^cell fusion at 37‡C using the £uorescence microscopy method. The experimental conditions are identical to those
described in the legend to Fig. 3. A and B ^ fusion of A2 and cp-52 strains respectively in the absence of inhibitor ; C and D ^ fusion of A2 virus and
cp-52 strains in the presence of 2 WM CL-309623. b: A: Normalized £uorescence spectra of CL-309623 in the absence and presence of A2 and cp-52 vi-
rus strains at 15‡C. Emission spectra of 200 nM of CL-309623 in the absence of virus (a) and in the presence of 5 Wg of either the A2 (E) or the cp-52
(7) virus strains. Emission spectra were obtained using an excitation maximum of 335 nm. The £uorescence intensity of the inhibitor in the presence of
the virus was normalized relative to the £uorescence of the free inhibitor. B: Normalized £uorescence spectra of CL-309623 in the absence (a) and pres-
ence (E) of 1 WM puri¢ed fusion protein at 15‡C. The experimental conditions are identical to those described in A. Fluorescence intensity of CL-
309623 in the presence of fusion protein was normalized relative to the £uorescence of the free inhibitor.
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On the basis of the above results, it is evident that
blockage of virus^cell attachment and fusion is responsible
for the observed antiviral activity of RFI-641 and that a
signi¢cant portion of the e¡ect has to do with inhibition of
fusion. The e¡ect of inhibitor on virus^cell binding is sig-
ni¢cantly higher in the £uorescence microscopy plate as-
says than the 20% observed in the suspension experiments.
The di¡erence in the extent of inhibition in the two assays
could be attributed to di¡erences in the morphology of the
Vero cells attached to the plate in the microscopy experi-
ments versus the cells in suspension in the £uorometric
assays. Di¡erences in the medium in which the cells are
suspended, MEM versus PBS, could be yet another possi-
bility. The physical state of the cells attached to the plate
versus those in suspension could be signi¢cantly di¡erent
in such a way that interactions with virus are altered in the
two states. In any event, the observed inhibition of virus
entry observed in both assays appears to be due to speci¢c
interactions of RFI-641 with the viral fusion protein. Sim-
ilarly, in the biological plaque reduction assay, a 20% re-
duction of virus^cell binding was observed (see Section 4).
Photoa⁄nity labeling experiments suggest that the tar-
get of this series of compounds is the F1 subunit of the
fusion protein. This experiment showed that analogs of
RFI-641 are bound predominantly (70%) to the F1 subunit
of the fusion protein with the remainder labeling the F2
subunit [24]. Since the F2 fragment is likely involved in
attachment, the result might be interpreted as binding at
the interface of the F1 and F2 fragments such that cross-
linking occurs to a greater extent on the F1 domain of the
fusion protein. However, inhibitor binding within or ad-
jacent to the heptad repeat sequences that are primarily
involved in conformational changes in other fusion pro-
teins cannot be excluded.
The lack of inhibition in the presence of WAY-158830
deserves comment. This could be due to lower binding
a⁄nity to the fusion protein on the virus and/or due to
a non-inhibitory binding orientation. Thus RFI-641 medi-
ates inhibition of virus entry via one or more of the fol-
lowing mechanisms: (i) inhibition of binding or displace-
ment of bound virus from cells due to speci¢c interactions
of the inhibitor with fusion protein, (ii) allosteric inhibi-
tion of fusion protein thereby blocking the formation of
fusion-active structures and apposition of the viral and cell
membranes. Since the biological activity is mediated by
interactions with fusion protein, inhibition of conforma-
tional changes of the fusion protein could be causally
linked to the inhibitory mechanism.
3. Signi¢cance
Human RSV is considered to be the leading cause of
upper and lower respiratory tract disease in infants and
young children. It is also a common pathogen in immu-
nocompromised adults and in the elderly. A novel class of
speci¢c inhibitors of RSV was discovered at Wyeth-Ayerst
through a screening program of which RFI-641 is cur-
rently a clinical candidate. While previous biological re-
sults suggested that the fusion event was inhibited, there
was no direct evidence for this mechanism of action. In
this work, we provide direct evidence that RFI-641 inhib-
its entry of RSV into host cells via inhibition of attach-
ment and fusion events. RFI-641 binds to the fusion pro-
tein on the viral surface, probably to a pre-fusogenic
conformation. It also appears to inhibit formation of an
intermediate structure along the pathway to viral fusion,
thereby inhibiting virus attachment and fusion. The results
reported here provide opportunities to design novel inhib-
itory agents of RSV due to a better understanding of
molecular events of RSV^cell interactions.
4. Materials and methods
The inhibitors were synthesized as disodium salts. The inhib-
itors were dissolved in 100% DMSO as a 1 mM stock solution.
Working stock solutions of the inhibitor were prepared by dilut-
ing the master stock solution into water to the required ¢nal
concentrations.
4.1. Cells
African green monkey kidney Vero (epithelial) cells were ob-
tained from American Type Culture Collection (ATCC). The cells
were maintained in Dulbecco’s modi¢ed Eagle media (DMEM),
(Gibco/BRL, Grand Island, NY, USA), supplemented with 10%
fetal bovine serum (FBS), 2 mM L-glutamine, 100 U of penicillin
and 100 ng of streptomycin per ml. The cells were routinely
maintained and grown at 37‡C in a 5% CO2 atmosphere.
4.2. Cell viability
The viability of infected and uninfected released Vero cells was
determined by the trypan blue exclusion method as 96^98%.
4.3. Viruses
Human RSV A2 strain (wild type) was obtained from Wyeth-
Lederle Vaccines, Pearl River, NY, USA. cp-52 RSV cold-pas-
saged mutant was kindly provided by Valerie Randolph from
Wyeth-Lederle Vaccines, Pearl River, NY, USA. Mutant RSV
cp-52, that lacks the G and SH genes, is a strain B candidate
vaccine. This cp-52 virus contains the fusion (F) protein as its
only glycoprotein and is infectious in cultured cells [14].
4.4. Virus puri¢cation
Puri¢cation of RSV virions was done as previously described
[25] with some modi¢cations. Virus stock solutions were prepared
by infecting Vero cells in roller bottles at a low multiplicity of
infection, which is typically less than one plaque forming unit
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(pfu) per cell. Infected cells were incubated at 37‡C for 3^4 days
until extensive syncytium formation occurred. One volume of
freezing medium (MEM, 10% FBS, 1U sucrose phosphate gluta-
mate bu¡er, 25 mM HEPES) was added and the bottles with
virus were quickly frozen in dry ice^methanol. The infected cells
were thawed quickly in a 37‡C water bath, sonicated for 2 min in
a Branson 1210 sonicator and Dounce-homogenized just prior to
beginning the puri¢cation procedure. Cells were pelleted by cen-
trifugation at 5000Ug at 4‡C for 20 min. Polyethylene glycol
(PEG) 6000 was added to supernatant to a ¢nal concentration
of 6.5% (w/v) and the solution was stirred at 4‡C for 1.5 h. The
virus was collected by centrifugation of the PEG solution at
5000Ug at 4‡C for 1 h and the pellet resuspended in NTE bu¡er
(100 mM NaCl, 100 mM Tris^HCl, pH 7.5 and 10 mM EDTA)
by Dounce homogenization. The resuspended virus was then
added to a tube containing two concentration layers of sucrose
in NTE bu¡er. Eight ml of 40% sucrose was layered on the top of
the tube and 1 ml of 60% sucrose at the bottom. Upon adding
virus the tube was spun at 25 000 rpm in an SW41 Ti rotor at 4‡C
for 2 h. The virus band at the interface of 40 and 60% sucrose
was harvested, resuspended in 20% sucrose in NTE bu¡er and
centrifuged on a 30^60% sucrose gradient at 30 000 rpm in an
SW41 Ti rotor at 4‡C for 2 h. The virus band was collected and
stored as 50 Wl aliquots, at 370‡C.
4.5. Plaque assay
Viral titer was measured by a plaque assay. Serial, 10-fold
dilutions of RSV A2 strain in DMEM with 2% FBS were used
to infect Vero cell monolayers on 6-well plates in duplicates for
1.5 h at room temperature. After virus adsorption the inoculum
was removed and infected cells were overlaid with 0.5% agarose
containing 1U MEM with 2% FBS and incubated at 37‡C.
Plaques developed after 6 days and were ¢xed by treatment
with 10% trichloroacetic acid for 15 min followed by 15 min
staining in 0.5% crystal violet in 80% methanol^PBS. RSV titers
as determined by plaque assay were: 2U107 pfu/ml for wild type
A2 strain, and 2U106 pfu/ml for the cp-52 mutant. The e¡ect of
inhibitor on virus^cell binding event was also measured by plaque
assay. Approximately 200^300 pfu of the virus were combined
with Vero cell monolayers on a 6-well plate in the presence of
2 WM of inhibitor, and incubated at 4‡C for 30 min. After virus
adsorption to cells in the presence of inhibitor, the inoculum was
removed and the cells were washed with MEM. The infected cells
were overlaid with 0.5% agarose containing MEM and incubated
at 37‡C and viral plaques estimated as described above.
4.6. Virus labeling procedure
The puri¢ed virus was labeled with the lipid probe octadecyl
rhodamine B chloride, R18 (Molecular Probes Inc., Eugene,
OR, USA), according to the procedure described previously
[13] with slight modi¢cations. Virus (200 Wg of total protein) in
300 Wl MEM was incubated with 5 Wg of R18 added as an etha-
nolic solution (5 ml). RSV and R18 were incubated at room
temperature for 1 h in the dark at ambient temperature. The
labeled virus was separated from unincorporated R18 probe by
gel ¢ltration on a G-25 Sephadex microspin column (Amika Cor-
poration, Columbia, MD, USA). The column was spun at
1500Ug for 4 min. The concentration of total protein in the virus
preparation was determined using a bicinchoninic acid assay kit
(Pierce, Rockford, IL, USA) and the procedure provided by the
supplier.
4.7. CL-309623 binding to RSV and fusion protein
An aliquot of virus (2 Wg equivalent in terms of total protein)
was added into a 500 Wl cuvette containing 1 WM of CL-309623 in
PBS, pH 7.4. The virus^inhibitor mixture was incubated for 3
min with magnetic stirring. The £uorescence spectra of the inhib-
itor were recorded on a FluoroMax-2 (Jobin-Yvon Spex, Edison,
NJ, USA) spectro£uorometer using excitation wavelength of 335
nm and emission spectral range of 400 nm to 550 nm. Fusion
protein puri¢ed from RSV (see [12] for puri¢cation procedure)
was diluted to a ¢nal concentration of 1 WM of protein and
0.001% of the detergent Triton X-100. In a control experiment
an identical concentration of the detergent was added to PBS
bu¡er to obtain £uorescence emission of CL-309623 in the bu¡er.
The sample compartment was maintained at a constant temper-
ature using a circulating water bath (Grant Instruments, Barring-
ton, UK).
4.8. Evaluation of RSV binding and fusion by £uorescent
microscopy
Vero cells in a 12-well plate containing 500 Wl of MEM (V60^
70% con£uent or V106 cells per well) were washed twice using
MEM. Labeled RSV (2 Wg of total protein) was added to each
well to yield approximately 5U109 virus particles based upon
estimations that used Sendai virus. The virus^cell ratio was ap-
proximately 5000 particles per cell [16].
To determine the e¡ect of inhibitor on attachment of virus to
cells, virus and inhibitor were added to each well at 4‡C. Plates
were incubated at 4‡C for 30 min in the dark with gentle rocking.
Unbound virus was removed by washing twice with ice-cold
MEM. The plates were then transferred to an incubator at
37‡C and incubated for 30 min to induce fusion.
To determine the e¡ect of inhibitor on the fusion event, a 2 Wg
aliquot of the labeled virus was added to cells at 4‡C and after
incubation for 30 min in the absence of inhibitor, unattached
virus was removed by washing with ice-cold MEM at 4‡C. A
10 Wl aliquot of a 100 WM stock solution of either RFI-641 or
WAY-158830 was added to the bound virus in the wells. In the
control well containing cells and attached virus, but lacking in-
hibitor, an equivalent volume of bu¡er was added. Approxi-
mately 1 min later the plate was incubated at 37‡C for 30 min.
To evaluate the e¡ect of compound on attachment and fusion
events, labeled virus (2 Wg) was incubated with cells similar to the
procedure described for the fusion alone experiment at 37‡C.
After incubating at 37‡C for 30 min, the unattached and unfused
virus was removed by washing the cells twice with MEM at
ambient temperature.
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The plates containing the labeled virus attached or fused to
Vero cells were imaged using a Nikon Eclipse TE200 microscope
consisting of a Spot0 Digital camera. The exposure time was pre-
set to be exactly the same for each well.
4.9. RSV binding to cells in suspension
The virus cell binding assays were performed as follows: Vero
cells in monolayers attached to the microtiter plate were released
by incubation with 500 Wl of PBS bu¡er in the absence of calcium
and magnesium for 10 min at 37‡C rather than by trypsinizing
the cells. The Vero cells were resuspended in 500 Wl of PBS and
equilibrated to a ¢nal temperature of either 4 or 37‡C. The la-
beled virus (equivalent to 2 Wg of total protein) was added to the
cells at 4 or 37‡C. After incubation for 30 min, the cells with
attached virus were centrifuged at 1500Ug for 3 min. The super-
natant was pooled and collected separately. The pellet was resus-
pended in 500 Wl of PBS. 2% SDS was added to both the super-
natant and pellet fractions. The £uorescence intensity of R18 was
measured at the maximum excitation and emission wavelengths
of 565 and 585 nm respectively. Percentage of bound fraction was
calculated as a ratio of R18 £uorescence in pellet relative to total
£uorescence. The fraction of virus particles bound to cells was
expressed as follows:
% of binding  Fpellet=Fpellet  F supernatantU100%
where Fpellet ^ £uorescence of R18 in pellet, Fsupernatant ^ £uores-
cence of R18 in supernatant.
In a separate experiment, virus pre-bound to cells at 4‡C in a
total volume of 500 Wl was centrifuged to separate the unattached
virus in the supernatant fraction. The pellet containing the at-
tached virus was resuspended in 50 Wl of PBS bu¡er. The 50 Wl
suspension was then added to a cuvette containing 450 Wl of
prewarmed solution of PBS bu¡er at 37‡C and incubated for
30 min. The virus^cell mixture was centrifuged once again to
pellet the attached and fused virus at 1500Ug for 3 min. 2%
SDS was added to the pellet to randomize the R18 dye according
to the procedure described above.
4.10. Spectro£uorometric measurements of RSV fusion by R18-
dequenching assay
The fusion of R18-labeled RSV was monitored as reported
earlier [15] with slight modi¢cations. The aliquot of virus (2 Wg
of protein) was added directly into a cuvette containing V106
cells, either in the presence or absence of an appropriate concen-
tration of inhibitor. The inhibitor was typically added to cells
1 min before the addition of virus. After brief mixing and equil-
ibration time (approximately 1 min later) the £uorescence of R18
at 560/585 nm excitation/emission wavelength (excitation and
emission slits of 2/2 nm) was recorded at time intervals of
1 min. 2% SDS was added into the suspension to maximize
R18 £uorescence. SDS detergent rather than Triton X-100 was
used to randomize R18 dye because in the presence of Triton
X-100 the background £uorescence was signi¢cantly higher. The
virus^cell mixture was incubated with SDS for 2 min at 37‡C.
The ¢nal value of R18 £uorescence was measured at the emission
maximum of the dye as described above.
To estimate kinetics of fusion of virus pre-bound to a cell, a
slightly modi¢ed version of the R18-dequenching assay was used.
The labeled virus was incubated with the cell suspension at 4‡C
with gentle rocking for 45 min. The cells with attached virus were
then pelleted by centrifugation at 1500Ug for 3 min. After re-
moving the supernatant, 50 Wl of PBS was added to the pellet.
The resuspended mixture in PBS was then added into a cuvette
prewarmed to 37‡C, either in the presence or absence of inhibitor.
Inhibitor was added immediately before (no more than 1 min)
addition of virus. Time-dependent changes in the £uorescence of
R18 due to viral fusion were monitored as described above for 30
min. At the end of the 30 min period, 2% SDS was added to the
cuvette to completely randomize the dye. Extent of dequenching
(DQ) value was calculated as described previously by other in-
vestigators [26].
DQ  F f3F0=Fdet3F0U100%
Where Ff ^ £uorescence intensity after incubation with target
cells at 37‡C, F0 ^ initial £uorescence of virus^cell suspension
after incubation at 4‡C, Fdet ^ £uorescence intensity after addi-
tion of detergent (maximum R18 dilution).
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